The CD81 antibody market focuses on reagents and therapeutics targeting CD81, a cell‑surface protein involved in cell adhesion, signaling, and viral entry. CD81 is widely studied in immunology, cancer biology, and infectious disease, and serves as a marker for exosomes and certain immune cell subsets.
The market was valued at around USD 700 million in 2024 and is projected to reach about USD...
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek